News | September 01, 2011

Hong Kong Sanatorium and Hospital Deploys GE PET/MRI System

Hong Kong Sanatorium and Hospital Deploys GE PET/MRI System

September 1, 2011 — Hong Kong Sanatorium & Hospital (HKSH) has selected GE Healthcare’s tri-modality imaging system, which may potentially enhance the ability of physicians to manage certain diseases. The system includes positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI).

Walton Li, M.D., medical superintendent of HKSH, emphasized the hospital’s commitment to medical research in the interest of patients and to advance treatment. “HKSH is not only a hospital that serves patients, but one that is committed to research and to the advancement of medical technology,” explained Li.

The future of PET/CT imaging is in therapy monitoring. Rather than just imaging patients at the beginning and end of a chemotherapy treatment, physicians may monitor patients more frequently to determine how well the treatment is working — that is, whether the tumor trends are going down or up.

The combination of MRI soft tissue contrast, PET metabolic insight, and precise CT anatomical reference, enabled by a patient transport system and image fusion, may hold promise for managing patient care.

The PET/CT + MR system consists of two scanning devices, a mobile patient system and the latest image registration application running on the company’s Advantage Workstation. This allows a patient to be moved from one device (PET/CT) to the other (MR) without changing positions on the table. The technology is designed to accurately capture images and correlate information from PET, CT and MRI imaging technologies.

For more information:

Related Content

A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer. Example of an Axumin PET scan.
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
News | Radiology Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...